Occult Blood Testing for Colorectal Cancer

  • Kevin K. Knight
  • Jonathan E. Fielding
  • Renaldo N. Battista
Part of the Frontiers of Primary Care book series (PRIMARY)


Colorectal cancer has long been the target of efforts aimed at early detection. It is the second most common cancer in the United States, with 140,000 new cases and 60,000 deaths estimated to have occurred in 1987.1 Uncommon in individuals under 50, its incidence increases sharply thereafter.2 Investigations into the causes of colorectal cancer have not yet yielded a consensus strategy for prevention. However, early treatment is generally acknowledged to be more beneficial than late treatment. Early detection thus seems to be a reasonable approach to lowering the toll of this cancer.


Colorectal Cancer Fecal Occult Blood Testing Barium Enema Occult Blood Fecal Occult Blood 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Silverberg E, Lubera J. Cancer statistics, 1987. CA 1987; 37:2–19.Google Scholar
  2. 2.
    National Cancer Institute. Surveillance, epidemiology and end-results: incidence and mortality data, 1973-77. Monograph No. 57. Bethesda, Md: 1981, 72.Google Scholar
  3. 3.
    Guidelines for the cancer-related checkup: recommendations and rationale. CA 1980;30:194–240.Google Scholar
  4. 4.
    Working guidelines for early detection approved by the National Cancer Institute advisory board, Sept. 30, 1987.Google Scholar
  5. 5.
    Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979; 121:1193–1247.Google Scholar
  6. 6.
    Brodie DR (ed). Screening and Early Detection of Colorectal Cancer. NIH Publ No. 80-2075. Wash-ington: US Department of Health, Education and Welfare, 1979.Google Scholar
  7. 7.
    Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985; 88:820–37.PubMedGoogle Scholar
  8. 8.
    Frank JW. Occult-blood screening for colorectal carcinoma: the benefits. Am J Prev Med 1985; 1(3):3–9.PubMedGoogle Scholar
  9. 9.
    Frank JW. Occult-blood screening for colorectal carcinoma: the risks. Am J Prev Med 1985;l(4):25–32.PubMedGoogle Scholar
  10. 10.
    Frank JW. Occult-blood screening for colorectal carcinoma: the yield and the costs. Am J Prev Med 1985; 1(5):18–24.PubMedGoogle Scholar
  11. 11.
    Chamberlain J, Day NI, Hakama M, et al. UICC workshop of the project on evaluation of screening programs for gastrointestinal cancer. Int J Cancer 1986; 37:329–34.PubMedCrossRefGoogle Scholar
  12. 12.
    Morson BC. Genesis of colorectal cancer. Clin Gastroenterol 1976; 5:505–25.PubMedGoogle Scholar
  13. 13.
    Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36:2251–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Lane N, Kaplan H, Pascal RR. Minute adenomatous and hyperplastic polyps of the colon. Gastroenterology 1971; 60:537–51.PubMedGoogle Scholar
  15. 15.
    Arthur JF. Structure and significance of metaplastic nodules in the rectal mucosa. J Clin Pathol 1968; 21:735.PubMedCrossRefGoogle Scholar
  16. 16.
    Tedesco FJ, Hendrix JC, Pickens CA, et al. Diminutive polyps: histopathology, spatial distribution, and clinical significance. Gastrointest Endosc 1982; 28:1–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Fenoglio-Preiser CM, Hutter RVP. Colorectal polyps: pathologic diagnosis and clinical significance. CA 1985; 35:323–45.Google Scholar
  18. 18.
    Sugarbaker PH, Gunderson LL, Wittes RE. Colorectal cancer. In Devita VT Jr, Hillman S, Rosenberg SA (eds). Cancer Principles and Practice of Oncology, 2d ed. Philadelphia: JB Lippincott, 1985, 795–884.Google Scholar
  19. 19.
    Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984; 35:425–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosevelt J, Frankl H. Colorectal cancer screening by nurse practitioner using 60-cm flexible fiber-optic sigmoidoscope. Dig Dis Sci 1984; 29:161–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Love RR, Morrissey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med 1984; 144:2209–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Demers RY, Demers P, Hoar SK, et al. Prevalence of colorectal polyps among Michigan pattern and model makers. J Occup Med 1985; 27:809–12.PubMedCrossRefGoogle Scholar
  23. 23.
    Wherry DC. Screening for colorectal neoplasia in asymptomatic patients using flexible fiber-optic sigmoidoscopy. Dis Colon Rectum 1981; 24:521–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Fenoglio CM, Pascal RR. Colorectal adenomas and cancer: pathologic relationships. Cancer 1982; 50:2601–8.PubMedGoogle Scholar
  25. 25.
    Greene FL. Distribution of colorectal neoplasms: a left to right shift of polyps and cancer. Am Surg 1983; 49:62–65.PubMedGoogle Scholar
  26. 26.
    Bat L, Pines A, Ron E, et al. Colorectal adenomatous polyps and carcinoma in Ashkenazi and non-Ashkenazi Jews in Israel. Cancer 1986; 58:1167–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Greegor DH. Diagnosis of large-bowel cancer in the asymptomatic patient. JAMA 1967; 201:943–45.PubMedCrossRefGoogle Scholar
  28. 28.
    Irons GV Jr, Kirsner JB. Routine chemical tests of the stool for occult blood: an evaluation. Am J Med Sci 1965; 249:247–60.PubMedCrossRefGoogle Scholar
  29. 29.
    Illingworth DG. Influence of diet on occult blood tests. Gut 1965; 6:595–98.PubMedCrossRefGoogle Scholar
  30. 30.
    Grossman MI, Matsumoto KK, Lichter RJ. Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 1961; 40:383–388.PubMedGoogle Scholar
  31. 31.
    Rees WD, Turnberg LA. Reappraisal of the effects of aspirin on the stomach. Lancet 1980; 2:410–13.PubMedCrossRefGoogle Scholar
  32. 32.
    Lifton LJ, Kreiser J. False-positive stool occult blood tests caused by iron preparations, a controlled study and review of literature. Gastroenterology 1982; 83:860–63.PubMedGoogle Scholar
  33. 33.
    Burton RM, Landreth KS, Barrows GH, et al. Appearance properties and origin of altered human hemoglobin in feces. Lab Invest 1976; 35:111–15.PubMedGoogle Scholar
  34. 34.
    Jaffe RM, Kasten B, Young DS, et al. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975; 83:824–26.PubMedGoogle Scholar
  35. 35.
    Morris DW, Hansell JR, Ostrow D, et al. Reliability of chemical tests for fecal occult blood in hospitalized patients. Dig Dis Sci 1976; 21:845–52.CrossRefGoogle Scholar
  36. 36.
    Herzog P, Holtermuller KH, Preiss J, et al. Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51 chromium-labeled erythrocytes and with the Hemoccult test. Gastroenterology 1982; 83:957–62.PubMedGoogle Scholar
  37. 37.
    Griffith CDM, Turner DJ, Saunders JH. False-negative results of Hemoccult test in colorectal cancer. Br Med J 1981; 283:472.CrossRefGoogle Scholar
  38. 38.
    Crowley ML, Freeman LD, Mottet MD, et al. Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol 1983; 5:127–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Rosenfield RE, Kochwa S, Kaczera Z, et al. Nonuni-form distribution of occult blood in feces. Am J Clin Pathol 1979; 71:204–9.PubMedGoogle Scholar
  40. 40.
    Macrae FA, St John DJB, Caligiore P, et al. Optimal dietary conditions for hemoccult testing. Gastroen-terology 1982; 82:899–903.Google Scholar
  41. 41.
    Heinrich HC, Icagic F. Comparative studies on the in vivo sensitivity of four commercial pseudoperoxidase-based faecal occult blood tests in relation to actual blood losses as calculated from measured whole body 59Fe-elimination rates. Klin Wochenschr 1980; 58:1283–97.PubMedCrossRefGoogle Scholar
  42. 42.
    Stroehlein JR, Fairbanks VF, McGill DB, et al. Hemoccult detection of fecal occult blood quantitated by radioassay. Dig Dis Sci 1976; 21:841–44.CrossRefGoogle Scholar
  43. 43.
    Gnauck R, Macrae FA, Fleisher M. How to perform the fecal occult blood test. CA 1984; 34:134–47.Google Scholar
  44. 44.
    Norfleet RG. 1,300 mg of aspirin daily does not cause positive fecal Hemoccult tests. J Clin Gastroenterol 1983; 5:123–25.PubMedCrossRefGoogle Scholar
  45. 45.
    Neuhauser D, Lewicki AM. What do we gain from the sixth stool guaiac? N Engl J Med 1975; 293:226–28.PubMedCrossRefGoogle Scholar
  46. 46.
    Wells HJ, Pagano JF. Hemoccult test-reversal of false-negative results due to storage (abstr). Gas-troenterology 1977; 72:1148.Google Scholar
  47. 47.
    Barrows GH, Burton RM, Jarrett DD, et al. Immunochemical detection of human blood in feces. Am J Clin Pathol 1978; 69:342–46.PubMedGoogle Scholar
  48. 48.
    Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood in the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 1980; 45:1099–1102.PubMedCrossRefGoogle Scholar
  49. 49.
    Armitage N, Hardcastle JD, Amar SS, et al. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer 1985; 51:799–804.PubMedCrossRefGoogle Scholar
  50. 50.
    Schwartz S, Dahl J, Ellefson M, et al. The Hemo-Quant test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials. Clin Chem 1983; 29:2061–67.PubMedGoogle Scholar
  51. 51.
    Alquist DA, McGill DB, Schwartz S, et al. Hemo-Quant, a new quantitative assay for fecal hemoglobin. comparison with Hemoccult. Ann Intern Med 1984; 101:297–302.Google Scholar
  52. 52.
    Alquist DA, McGill DB, Schwartz S, et al. Fecal blood levels in health and disease: a study using HemoQuant. N Engl J Med 1985; 312:1422–28.CrossRefGoogle Scholar
  53. 53.
    Peterson WL, Fordtran JS. Quantitating the occult (editorial). N Engl J Med 1985; 312:1448–49.PubMedCrossRefGoogle Scholar
  54. 54.
    Eddy DM, Nugent FW, Eddy JF, et al. Screening for colorectal cancer in a high risk population: results of a mathematical model. Gastroenterology 1987; 92:682–92.PubMedGoogle Scholar
  55. 55.
    Cole P, Morrison AS. Basic issues in population screening for cancer. JNCI 1980; 64:1263–72.PubMedGoogle Scholar
  56. 56.
    Hughes LE. The incidence of benign and malignant neoplasms of the colon and rectum: a postmortem study. Aust NZ J Surg 1968; 38:30–35.Google Scholar
  57. 57.
    Rickert RR, Auerback O, Garfinke L, et al. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979; 43:1847–57.PubMedCrossRefGoogle Scholar
  58. 58.
    Williams AR, Balasooriy BAW, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23:835–42.PubMedCrossRefGoogle Scholar
  59. 59.
    Hastings JB. Mass screening for colorectal cancer. Am J Surg 1974; 127:228–33.PubMedCrossRefGoogle Scholar
  60. 60.
    Miller SR, Knight AR. The early detection of colorectal cancer. Cancer 1977; 40:945–49.PubMedCrossRefGoogle Scholar
  61. 61.
    Goodman MJ. Mass screening for colorectal cancer: a negative report. JAMA 1977; 237:2380.Google Scholar
  62. 62.
    Helfrich GB, Petrucci P, Webb H. Mass screening for colorectal cancer. JAMA 1977; 237:2380.Google Scholar
  63. 63.
    Fruhmorgen P, Demling L. Early detection of colorectal carcinoma with a modified guaiac test, a screening examination in 6000 humans. Acta Gastroenterol Belg 1978; 41:682–87.PubMedGoogle Scholar
  64. 64.
    Heeb MA, Ahlvin RC. Screening for colorectal carcinoma in a rural area. Surgery 1978; 83:540–41.PubMedGoogle Scholar
  65. 65.
    El wood TW, Erickson A, Lieberman S. Comparative educational approaches to screening for colorectal cancer. Am J Public Health 1978; 68:135–38.CrossRefGoogle Scholar
  66. 66.
    Winchester DP, Shull JH, Scanlon EF, et al. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer 1980; 45:2955–58.PubMedCrossRefGoogle Scholar
  67. 67.
    Kurnick JE, Walley LB, Jacob HH, et al. Colorectal cancer detection in a community hospital screening program. JAMA 1980; 243:2056–57.PubMedCrossRefGoogle Scholar
  68. 68.
    Schwartz FW, Holstein H, Brecht JG. Preliminary report of fecal occult blood testing in Germany. In Winawer SJ, Schottenfeld D, Sherlock P (eds). Colorectal Cancer: Prevention, Epidemiology, and Screening. New York: Raven, 1980, 267–70.Google Scholar
  69. 69.
    Larkin KK. Mass screening in colorectal cancer. Aust NZ J Surg 1980; 50:467–69.CrossRefGoogle Scholar
  70. 70.
    Chambers KJ, Morgan BP. Colorectal cancer and Hemoccult. Aust NZ J Surg 1980; 50:464–67.CrossRefGoogle Scholar
  71. 71.
    Stuart M, Killingback MJ, Sakker S, et al. Hemoccult II test: routine screening procedure for colorectal neoplasm? Med J Aust 1981; 1:629–31.PubMedGoogle Scholar
  72. 72.
    Farrands PA, Griffiths RL, Britton DC. The Frome experiment: value of screening for colorectal cancer. Lancet 1981; 1:1231–32.PubMedCrossRefGoogle Scholar
  73. 73.
    Million R, Howarth J, Turnberg E, et al. Faecal occult blood testing for colorectal cancer in general practice. Practitioner 1982; 226:659–63.PubMedGoogle Scholar
  74. 74.
    Sontag SJ, Durczak C, Aranha GV, et al. Fecal occult blood screening for colorectal cancer in a Veterans Administration hospital. Am J Surg 1983; 145:89–93.PubMedCrossRefGoogle Scholar
  75. 75.
    Siba S. Experience with Haemoccult screening in Hungary: a multicenter trial. Hepatogastroenterol- ogy 1983; 30:27–29.Google Scholar
  76. 76.
    Habba SF, Doyle JS. Colorectal cancer screening of asymptomatic patients in Ireland. Ir J Med Sci 1983; 152:121–24.PubMedCrossRefGoogle Scholar
  77. 77.
    Hoffman A, Young Q, Bright-Asare P, et al. Early detection of bowel cancer at an urban public hospital: demonstration project. CA 1983; 33:344–58.Google Scholar
  78. 78.
    Cummings KM, Michalek A, Mettlin C, et al. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test. Cancer 1984; 53:2201–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Winawer SJ, Andrews M, Flehinger B, et al. Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia. Cancer 1980; 45:2959–64.PubMedCrossRefGoogle Scholar
  80. 80.
    Gilbertsen VA, Church TR, Grewe FJ. The design of a study to assess occult-blood screening for colon cancer. J Chronic Dis 1980; 33:107–14.PubMedCrossRefGoogle Scholar
  81. 81.
    Gilbertsen VA, McHugh RB, Schuman LM, et al. The earlier detection of colorectal cancers: a preliminary report of the results of the occult blood study. Cancer 1980; 45:2899–2901.PubMedCrossRefGoogle Scholar
  82. 82.
    Gilbertsen V. Colon cancer screening: the Minnesota experience. Gastrointest Endosc 1980; 26:31S–32S.PubMedCrossRefGoogle Scholar
  83. 83.
    Hardcastle JD, Armitage NC, Chamberlain J, et al. Fecal occult blood screening for colorectal cancer in the general population: results of a controlled trial. Cancer 1986; 58:397–403.PubMedCrossRefGoogle Scholar
  84. 84.
    Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983; 24:376–83.PubMedCrossRefGoogle Scholar
  85. 85.
    Doran J, Hardcastle JD. Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg 1982; 69:711–13.PubMedCrossRefGoogle Scholar
  86. 86.
    Macrae FA, St John DJB. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82:891–98.PubMedGoogle Scholar
  87. 87.
    Ribet A, Frexinos J, Escourrou J, et al. Occult blood tests and colorectal tumours. Lancet 1980; 1:417.PubMedCrossRefGoogle Scholar
  88. 88.
    Applegate WB, Spector MH. Colorectal cancer screening. J Community Health 1981; 7:138–51.PubMedCrossRefGoogle Scholar
  89. 89.
    Gnauk R. Screening tests nach Darmkrebs: erneuter Vergleich von Haemoccult mit hemoFEC und Ruck- blick auf 9 Jahre klinische Erfahrung mit Haemoccult. Z Gastroenterologie 1982; 20:84–92.Google Scholar
  90. 90.
    Demers RY, Stawick LE, Demers P. Relative sensitivity of the fecal occult blood test and flexible sigmoidoscopy in detecting polyps. Prev Med 1985; 14:55–62.PubMedCrossRefGoogle Scholar
  91. 91.
    Macklin MT. Inheritance of cancer of the stomach and large intestine in man. JNCI 1960; 24:551–71.PubMedGoogle Scholar
  92. 92.
    Lovet E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63:13–18.CrossRefGoogle Scholar
  93. 93.
    Lynch HT, Lynch PM, Albana WA, et al. Hereditary cancer: ascertainment and management. CA 1979; 29:216–32.Google Scholar
  94. 94.
    National Institutes of Health. Third national cancer survey: hospitalization and payments to hospitals. Washington: US Department of Health, Education and Welfare, 1976.Google Scholar
  95. 95.
    Kristein MM. The economics of screening for colorectal cancer. Soc Sci Med 1980; 14C:275–84.Google Scholar
  96. 96.
    Survey of physicians’ attitudes and practices in early cancer detection. CA 1984; 35:197–213.Google Scholar
  97. 97.
    Gilson BS, Michnich ME, Thompson RS, et al. Physician Effectiveness in Preventive Care: Final Report. Submitted to the National Center for Health Services Research, US Department of Health and Human Services, 1987.Google Scholar
  98. 98.
    Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal occult blood screening: a critical review. Prev Med 1987; 16:9–18.PubMedCrossRefGoogle Scholar
  99. 99.
    Selby JV, Friedman GD. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser-Permanente Multiphasic Evaluation Study. J Clin Epidemiol 1988; 41:427–434.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • Kevin K. Knight
  • Jonathan E. Fielding
  • Renaldo N. Battista

There are no affiliations available

Personalised recommendations